Intensivmedizin up2date, Table of Contents Intensivmedizin up2date 2014; 10(02): 129-151DOI: 10.1055/s-0034-1365715 Internistische Intensivmedizin © Georg Thieme Verlag KG Stuttgart · New YorkDas akute Koronarsyndrom Dawid L. Staudacher , Paul M. Biever , Christoph Bode , Tobias WengenmayerRecommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Thygesen K et al. Third universal definition of myocardial infarction. Circulation 126: 2020-2035 2 Yeh RW et al. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. N Engl J Med 2010; 362: 2155-2165 3 Roger VL et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220 4 Steg PG et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33: 2569-2619 5 Hamm CW et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32: 2999-3054 6 Kerr G et al. Elevated troponin after stroke: a systematic review. Cerebrovasc Dis 2009; 28: 220-226 7 Thelin J et al. The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study. BMC Cardiovasc Disord 13: 42 8 Chen ZM et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1622-1632 9 Arntz HR et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 5. Initial management of acute coronary syndromes. Resuscitation 81: 1353-1363 10 Cabello JB et al. Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev 2013; (8) CD007160 11 Montalescot G et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 2013; 369: 999-1010 12 Gibson CM. Time is myocardium and time is outcomes. Circulation 2001; 104: 2632-2634 13 Silber S et al. Kommentare zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Therapie von Patienten mit ST-Streckenhebungsinfarkt (STEMI). Kardiologe 2010; 4: 84-92 14 Dalby M et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003; 108: 1809-1814 15 Keele EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20 16 Bonnefoy E et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002; 360: 825-829 17 Reynolds HR, Hochman JS. Cardiogenic Shock: Current Concepts and Improving Outcomes. Circulation 2008; 117: 686-697 18 Thackray S et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail 2002; 4: 515-529 19 Silber S, Hoffmeister HM, Bode C. Optimal platelet inhibition after coronary stent implantation. Current status. Herz 2008; 33: 244-253 20 Frobert O et al. Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction. N Engl J Med 2013; 369: 1587-1597 21 Wald DS et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013; 369: 1115-1123 22 Tang EW, Wong CK. HerbisonGlobal Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007; 153: 29-35 23 Subherwal S et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 2009; 119: 1873-1882 24 Achenbach S et al. Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Therapie des akuten Koronarsyndroms ohne persistierende ST-Streckenhebung. Kardiologe 2012; 6: 283-301 25 Mohr FW et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381: 629-638 26 Wallentin L et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057 27 Wiviott SD et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-2015 28 Homma S et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366: 1859-1869 29 Mega JL et al. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). J Am Coll Cardiol 2013; 61: 1853-1859 30 Mancia G et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219
